Sort
40,608 grants matching “prostate cancer”
MESENCHYMAL STEM CELL CONTROL OF METASTATIC PROSTATE CANCER CELL EVOLUTION AND THERAPY RESISTANCE IN THE BONE MICROENVIRONMENT
$943,436H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc. · · FY2018 · Defense Health Agency
VALIDATION OF FAMILY HISTORY OF CANCER QUESTIONNAIRE
$943,237Westat, Inc. · N01 · FY2000 · PC
Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance
$943,099Antonio Fojo · Basic Sciences · Z01 · FY2007 · CA
GENETIC SUSCEPTIBILITY TO CANCER IN MULTIETHNIC COHORTS
$942,733University Of Southern California · U01 · FY2000 · CA
Research Infrastructure Core
$942,530Song Gao · Texas Southern University · U54 · FY2024 · MD
RADIOLABELED PARP INHIBITORS FOR IMAGING AND TARGETED RADIOTHERAPY OF PROSTATE CANCER
$942,353Washington University, The · · FY2019 · Department of the Army
NOVEL ROLES OF STUB1 IN RESISTANT PROSTATE CANCER
$942,000University Of California, Davis · · FY2019 · Department of the Army
Office of Cancer Genomics
$941,752Douglas R. Lowy · Office Of The Director, Nci · ZIA · FY2010 · CA
A Novel Therapeutic that Harnesses Microtubules to Promote Cavernous Nerve Regeneration after Radical Prostatectomy
$941,635Lisa Ann Baker · Microcures, Inc. · R42 · FY2021 · DK
Ultrasound Ablation on Bone Cancer Under CT Fluoroscopy
$941,541Everette C Burdette · Acoustic Medsystems, Inc. · R44 · FY2012 · CA
SELENIUM BASED CHEMOPREVENTION
$941,476Cancer Therapy And Research Center · U01 · FY2000 · CA
Core - Histopathology Composite
$941,112Edward J Benz · Dana-Farber Cancer Inst · P30 · FY2007 · CA
Proteomic Analysis of Blood Plasma using High Throughput Sequencers
$940,715Mark Patrick McPike · Aptamatrix, Inc. · R44 · FY2020 · GM
Engagement Optimization Unit
$940,580Jennifer W Mack · Broad Institute, Inc. · U2C · FY2025 · CA
High throughput infrastructure for reaction screening and bioassays
$940,354Robert Graham Cooks · Purdue University · UG3 · FY2023 · TR
Nutrition, Metabolism, and Cancer
$940,099Regina G Ziegler · Division Of Cancer Epidemiology And Genetics · ZIA · FY2012 · CA
EXPANDING AN ACTIVE SURVEILLANCE COHORT TO IMPROVE SURVIVORSHIP FOR BLACK MEN WITH FAVORABLE-RISK PROSTATE CANCER.
$939,940Northwestern University · · FY2021 · Defense Health Agency
Targeted Nanoparticles for Tempospatially Controlled Combination Chemotherapy
$938,701Robert S Langer · Massachusetts Institute Of Technology · U54 · FY2011 · CA
Illinois Oncology Research Association CCOP
$938,655John W Kugler · Oncology-Hematology Assoc-Central Ill · U10 · FY2008 · CA
Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
$938,510University Of Colorado Denver · N01 · FY2010 · CA
FLEX TM microPET/SPECT/CT to Support Cancer Research at Harvard Medical School
$938,175John V Frangioni · Beth Israel Deaconess Medical Center · S10 · FY2006 · RR
The connection of innate and adaptive anti-cancer immunity
$937,885John Greiner · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Enabling Next Generation Machine Learning for Large Scale Image Analysis
$937,441Gerald Sabin · Rnet Technologies, Inc. · R44 · FY2023 · EB
Enabling Technologies for MRI-Guided Prostate Interventions
$937,291Clare M Tempany · Brigham And Women'S Hospital · R01 · FY2012 · CA
Minority Based Community Clinical Oncology Program
$936,500David J Peace · University Of Illinois At Chicago · U10 · FY2008 · CA